We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
An Activating Mutation in ERK Causes Hyperplastic Tumors in a scribble Mutant Tissue in Drosophila.
- Authors
Kushnir, Tatyana; Bar-Cohen, Shaked; Mooshayef, Navit; Lange, Rotem; Bar-Sinai, Allan; Rozen, Helit; Salzberg, Adi; Engelberg, David; Paroush, Ze'ev
- Abstract
Receptor tyrosine kinase signaling plays prominent roles in tumorigenesis, and activating oncogenic point mutations in the core pathway components Ras, Raf, or MEK are prevalent in many types of cancer. Intriguingly, however, analogous oncogenic mutations in the downstream effector kinase ERK have not been described or validated in vivo. To determine if a point mutation could render ERK intrinsically active and oncogenic, we have assayed in Drosophila the effects of a mutation that confers constitutive activity upon a yeast ERK ortholog and has also been identified in a few human tumors. Our analyses indicate that a fly ERK ortholog harboring this mutation alone (RolledR80S), and more so in conjunction with the known sevenmaker mutation (RolledR80S+D334N), suppresses multiple phenotypes caused by loss of Ras-Raf-MEK pathway activity, consistent with an intrinsic activity that is independent of upstream signaling. Moreover, expression of RolledR80S and RolledR80S+D334N induces tissue overgrowth in an established Drosophila cancer model. Our findings thus demonstrate that activating mutations can bestow ERK with pro-proliferative, tumorigenic capabilities and suggest that Drosophila represents an effective experimental system for determining the oncogenicity of ERK mutants and their response to therapy.
- Subjects
ANIMAL experimentation; BIOLOGICAL models; CELLULAR signal transduction; GENE expression; GENES; INSECTS; TRANSFERASES; TUMORS; PHENOTYPES; GAIN-of-function mutations
- Publication
Genetics, 2020, Vol 214, Issue 1, p109
- ISSN
0016-6731
- Publication type
Article
- DOI
10.1534/genetics.119.302794